These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22973038)

  • 1. Long-term nonprogressor and elite controller patients who control viremia have a higher percentage of methylation in their HIV-1 proviral promoters than aviremic patients receiving highly active antiretroviral therapy.
    Palacios JA; Pérez-Piñar T; Toro C; Sanz-Minguela B; Moreno V; Valencia E; Gómez-Hernando C; Rodés B
    J Virol; 2012 Dec; 86(23):13081-4. PubMed ID: 22973038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals.
    Trejbalová K; Kovářová D; Blažková J; Machala L; Jilich D; Weber J; Kučerová D; Vencálek O; Hirsch I; Hejnar J
    Clin Epigenetics; 2016; 8():19. PubMed ID: 26900410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of genetic diversity reduction in the HIV-1 integrated proviral LTR sequence population during successful combination therapy.
    Ibáñez A; Clotet B; Martínez MA
    Virology; 2001 Mar; 282(1):1-5. PubMed ID: 11259184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic analysis of HIV-1 proviral genomes from infected individuals: predominance of unmethylated CpG's.
    Weber S; Weiser B; Kemal KS; Burger H; Ramirez CM; Korn K; Anastos K; Kaul R; Kovacs C; Doerfler W
    Virology; 2014 Jan; 449():181-9. PubMed ID: 24418551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal variation in human immunodeficiency virus long terminal repeat methylation in individuals on suppressive antiretroviral therapy.
    Cortés-Rubio CN; Salgado-Montes de Oca G; Prado-Galbarro FJ; Matías-Florentino M; Murakami-Ogasawara A; Kuri-Cervantes L; Carranco-Arenas AP; Ormsby CE; Cortés-Rubio IK; Reyes-Terán G; Ávila-Ríos S
    Clin Epigenetics; 2019 Sep; 11(1):134. PubMed ID: 31519219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decay of human immunodeficiency virus type 1 unintegrated DNA containing two long terminal repeats in infected individuals after 3 to 8 years of sustained control of viremia.
    McDermott JL; Martini I; Ferrari D; Bertolotti F; Giacomazzi C; Murdaca G; Puppo F; Indiveri F; Varnier OE
    J Clin Microbiol; 2005 Oct; 43(10):5272-4. PubMed ID: 16207994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG methylation controls reactivation of HIV from latency.
    Blazkova J; Trejbalova K; Gondois-Rey F; Halfon P; Philibert P; Guiguen A; Verdin E; Olive D; Van Lint C; Hejnar J; Hirsch I
    PLoS Pathog; 2009 Aug; 5(8):e1000554. PubMed ID: 19696893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG Methylation Profiles of HIV-1 Pro-Viral DNA in Individuals on ART.
    Boltz VF; Ceriani C; Rausch JW; Shao W; Bale MJ; Keele BF; Hoh R; Milush JM; Deeks SG; Maldarelli F; Kearney MF; Coffin JM
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33946976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paucity of HIV DNA methylation in latently infected, resting CD4+ T cells from infected individuals receiving antiretroviral therapy.
    Blazkova J; Murray D; Justement JS; Funk EK; Nelson AK; Moir S; Chun TW; Fauci AS
    J Virol; 2012 May; 86(9):5390-2. PubMed ID: 22345448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections.
    Anderson EM; Simonetti FR; Gorelick RJ; Hill S; Gouzoulis MA; Bell J; Rehm C; Pérez L; Boritz E; Wu X; Wells D; Hughes SH; Rao V; Coffin JM; Kearney MF; Maldarelli F
    Viruses; 2020 Jan; 12(2):. PubMed ID: 31991737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term suppression of HIV-1C virus production in human peripheral blood mononuclear cells by LTR heterochromatization with a short double-stranded RNA.
    Singh A; Palanichamy JK; Ramalingam P; Kassab MA; Bhagat M; Andrabi R; Luthra K; Sinha S; Chattopadhyay P
    J Antimicrob Chemother; 2014 Feb; 69(2):404-15. PubMed ID: 24022068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen.
    Delaugerre C; Charreau I; Braun J; Néré ML; de Castro N; Yeni P; Ghosn J; Aboulker JP; Molina JM; Simon F;
    AIDS; 2010 Sep; 24(15):2391-5. PubMed ID: 20683319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection.
    Brussel A; Mathez D; Broche-Pierre S; Lancar R; Calvez T; Sonigo P; Leibowitch J
    AIDS; 2003 Mar; 17(5):645-52. PubMed ID: 12646786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The largest HIV-1-infected T cell clones in children on long-term combination antiretroviral therapy contain solo LTRs.
    Botha JC; Demirov D; Gordijn C; Katusiime MG; Bale MJ; Wu X; Wells D; Hughes SH; Cotton MF; Mellors JW; Kearney MF; van Zyl GU
    mBio; 2023 Aug; 14(4):e0111623. PubMed ID: 37530525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy.
    Ostrowski SR; Katzenstein TL; Thim PT; Pedersen BK; Gerstoft J; Ullum H
    J Infect Dis; 2005 Feb; 191(3):348-57. PubMed ID: 15633093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
    Re MC; Vitone F; Biagetti C; Schiavone P; Alessandrini F; Bon I; de Crignis E; Gibellini D
    Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association of HIV type 1 long terminal repeat sequence pattern with long-term nonprogression and in vivo viral replication levels in European subjects.
    Visco-Comandini U; Yun Z; Vahlne A; Sönnerborg A
    AIDS Res Hum Retroviruses; 1999 May; 15(7):609-17. PubMed ID: 10331439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of mutations in proviral long terminal repeats of HIV type 1-infected subjects naive to drug therapy.
    Copeland KF; Chen Z; Fiebig M; Ni L; Savoy S; Smaill FM; Rosenthal KL; Kim JE
    AIDS Res Hum Retroviruses; 2004 Sep; 20(9):1019-21. PubMed ID: 15585090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut mucosal viral reservoir in HIV-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapy.
    Lerner P; Guadalupe M; Donovan R; Hung J; Flamm J; Prindiville T; Sankaran-Walters S; Syvanen M; Wong JK; George MD; Dandekar S
    J Virol; 2011 May; 85(10):4772-82. PubMed ID: 21345945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor.
    Salvi R; Garbuglia AR; Di Caro A; Pulciani S; Montella F; Benedetto A
    J Virol; 1998 May; 72(5):3646-57. PubMed ID: 9557645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.